ATEYY Quote, Financials, Valuation and Earnings

OMRON has a net margin of 17.21% compared to Advantest's net margin of -5.24%. Advantest's return on equity of 18.54% beat OMRON's return on equity of -1.69%.

Advantest has a consensus price target of --, signalling downside risk potential of --. On the other hand OMRON has an analysts' consensus of -- which suggests that it could fall by --. Given that Advantest has higher upside potential than OMRON, analysts believe Advantest is more attractive than OMRON.

Advantest has a beta of 1.407, which suggesting that the stock is 40.706% more volatile than S&P 500. In comparison OMRON has a beta of 1.033, suggesting its more volatile than the S&P 500 by 3.284%.

Advantest has a quarterly dividend of $0.13 per share corresponding to a yield of 0.42%. OMRON offers a yield of 2.02% to investors and pays a quarterly dividend of $0.35 per share. Advantest pays 39.94% of its earnings as a dividend. OMRON pays out 245.34% of its earnings as a dividend. Advantest's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but OMRON's is not.

Advantest quarterly revenues are $889.9M, which are smaller than OMRON quarterly revenues of $1.2B. Advantest's net income of $153.1M is higher than OMRON's net income of -$61.7M. Notably, Advantest's price-to-earnings ratio is 82.47x while OMRON's PE ratio is 105.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Advantest is 12.09x versus 1.22x for OMRON. Usually stocks with elevated PS ratios are considered overvalued.

Rohm has a net margin of 17.21% compared to Advantest's net margin of 2.93%. Advantest's return on equity of 18.54% beat Rohm's return on equity of 3.94%.

Advantest has a consensus price target of --, signalling downside risk potential of --. On the other hand Rohm has an analysts' consensus of -- which suggests that it could fall by --. Given that Advantest has higher upside potential than Rohm, analysts believe Advantest is more attractive than Rohm.

Advantest has a beta of 1.407, which suggesting that the stock is 40.706% more volatile than S&P 500. In comparison Rohm has a beta of 1.015, suggesting its more volatile than the S&P 500 by 1.474%.

Advantest has a quarterly dividend of $0.13 per share corresponding to a yield of 0.42%. Rohm offers a yield of 3.55% to investors and pays a quarterly dividend of $0.17 per share. Advantest pays 39.94% of its earnings as a dividend. Rohm pays out 36.07% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Advantest quarterly revenues are $889.9M, which are larger than Rohm quarterly revenues of $758.7M. Advantest's net income of $153.1M is higher than Rohm's net income of $22.2M. Notably, Advantest's price-to-earnings ratio is 82.47x while Rohm's PE ratio is 9.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Advantest is 12.09x versus 1.14x for Rohm. Usually stocks with elevated PS ratios are considered overvalued.

Tokyo Electron has a net margin of 17.21% compared to Advantest's net margin of 22.73%. Advantest's return on equity of 18.54% beat Tokyo Electron's return on equity of 22.49%.

Advantest has a consensus price target of --, signalling downside risk potential of --. On the other hand Tokyo Electron has an analysts' consensus of -- which suggests that it could fall by --. Given that Advantest has higher upside potential than Tokyo Electron, analysts believe Advantest is more attractive than Tokyo Electron.

Advantest has a beta of 1.407, which suggesting that the stock is 40.706% more volatile than S&P 500. In comparison Tokyo Electron has a beta of 1.506, suggesting its more volatile than the S&P 500 by 50.635%.

Advantest has a quarterly dividend of $0.13 per share corresponding to a yield of 0.42%. Tokyo Electron offers a yield of 2.19% to investors and pays a quarterly dividend of $0.88 per share. Advantest pays 39.94% of its earnings as a dividend. Tokyo Electron pays out 55.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Advantest quarterly revenues are $889.9M, which are smaller than Tokyo Electron quarterly revenues of $3.6B. Advantest's net income of $153.1M is lower than Tokyo Electron's net income of $809.5M. Notably, Advantest's price-to-earnings ratio is 82.47x while Tokyo Electron's PE ratio is 24.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Advantest is 12.09x versus 5.28x for Tokyo Electron. Usually stocks with elevated PS ratios are considered overvalued.

TDK has a net margin of 17.21% compared to Advantest's net margin of 1.07%. Advantest's return on equity of 18.54% beat TDK's return on equity of 7.73%.

Advantest has a consensus price target of --, signalling downside risk potential of --. On the other hand TDK has an analysts' consensus of -- which suggests that it could grow by 20.74%. Given that TDK has higher upside potential than Advantest, analysts believe TDK is more attractive than Advantest.

Advantest has a beta of 1.407, which suggesting that the stock is 40.706% more volatile than S&P 500. In comparison TDK has a beta of 0.884, suggesting its less volatile than the S&P 500 by 11.579%.

Advantest has a quarterly dividend of $0.13 per share corresponding to a yield of 0.42%. TDK offers a yield of 1.31% to investors and pays a quarterly dividend of $0.09 per share. Advantest pays 39.94% of its earnings as a dividend. TDK pays out 33.81% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Advantest quarterly revenues are $889.9M, which are smaller than TDK quarterly revenues of $3.3B. Advantest's net income of $153.1M is higher than TDK's net income of $35M. Notably, Advantest's price-to-earnings ratio is 82.47x while TDK's PE ratio is 29.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Advantest is 12.09x versus 1.66x for TDK. Usually stocks with elevated PS ratios are considered overvalued.